UNITED STATES: Substance Use, Medications for Sexual Facilitation, and Sexual Risk Behavior Among Traveling Men Who Have Sex with Men CDC Daily UpdateImportant note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow



UNITED STATES: Substance Use, Medications for Sexual Facilitation, and Sexual Risk Behavior Among Traveling Men Who Have Sex with Men

Sexually Transmitted Diseases Vol. 33; No. 12: P. 706-711 (12..06) - Wednesday, December 27, 2006
Eric G. Benotsch, PhD; Salvatore Seeley, MSW; John J. Mikytuck, BS; Steven D. Pinkerton, PhD; Christopher D. Nettles, MA; Kathleen Ragsdale, PhD


The researchers undertook the current study to examine the correlates of sexual risk behavior among men who have sex with men (MSM) while traveling for leisure.

The subjects were 304 MSM visiting popular tourist areas. They completed a brief survey on sexual behavior and substances used while on vacation, including erectile dysfunction (ED) drugs.

Of the men, 47 percent reported sexual activity while on vacation, with a mean of 1.33 unprotected anal sex acts during their brief stay (mean: 3.6 days). Of those men who had sex, more than half reported sex with a partner of unknown HIV serostatus. Higher rates of sexual risk behaviors were reported by men who used substances or ED drugs.

The authors concluded, "Many MSM travelers report behaviors that may put their health at risk, including substance use and unprotected sexual activity. Interventions designed to reduce risk behaviors among MSM tourists are needed."
061227
AD062503


Copyright © 2006 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.